POTENTIAL DEAL DETAILS
|Date Announced||05/07/2018||Source||The Wall Street Journal|
|Type||Unsolicited Bid||Acquiring Company/Person||an affiliate of Veritas and Evergreen|
|Date of Confirmation:||11/12/2018||Price at Confirmation:||$131.97|
|Potential Profit:||-10.07%||Annualized Profit:||-19.45%|
October 12, 2018: Athenahealth Inc. (ATHN) is attracting interest from at least five potential bidders as an auction for the health record technology company nears an end, according to people familiar with the offer.
October 31, 2018: Private equity firm Veritas Capital has teamed up with Elliott Management Corp. to bid for health-care technology company Athenahealth Inc.(ATHN), according to people familiar with the matter.
November 11, 2018: Private equity firm Veritas Capital and hedge fund Elliott Management have agreed to buy US healthcare technology group Athenahealth (ATHN) for $5.5bn, according to three people with knowledge of the deal.
November 12, 2018: Athenahealth (ATHN), a leading provider of network-enabled services for hospital and ambulatory customers nationwide, Veritas Capital and Evergreen Coast Capital, today announced that they have entered into a definitive agreement under which an affiliate of Veritas and Evergreen will acquire Athenahealth (ATHN) for approximately $5.7 billion in cash.
Disclaimer: Our intent with this section of the website is to present potential deals that appear to be in the pipeline. These potential deals are ones where i) the company has indicated that it is "seeking strategic alternatives", ii) there has been an unsolicited bid for a company as mentioned in a press release by the company or iii) news about the deal has been published by a leading news organization like The Wall Street Journal, The New York Times, Bloomberg, Financial Times, The Washington Post, Reuters and The Associated Press. As best as possible we will try to avoid baseless rumors. There is a high probability that many of these potential deals may not materialize and if they do, the terms of the deal may be different from what was initially reported. Please do your own due diligence before buying or selling any securities mentioned on this website. We do not warrant the completeness or accuracy of the content or data provided.